Glenmede Trust’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Glenmede Trust’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-16,000	Closed	–	–	3255
2019 Q3	$0	Hold	16,000	–	–	﹤0.01%	3256
2019 Q2	$0	Hold	16,000	–	–	﹤0.01%	3308
2019 Q1	$0	Hold	16,000	–	–	﹤0.01%	3318
2018 Q4	$0	Sell	16,000 -28,000	-64%	–	﹤0.01%	3180
2018 Q3	$1K	Sell	44,000 -16,000	-27%	-$4.09K	﹤0.01%	1419
2018 Q2	$21K	Buy	60,000 +52,000	+650%	+$42.7K	﹤0.01%	1712
2018 Q1	$11K	Hold	8,000	–	–	﹤0.01%	2159
2017 Q4	$11K	Sell	8,000 -1,900	-19%	-$3.12K	﹤0.01%	2159
2017 Q3	$22K	Sell	9,900 -145	-1%	-$194	﹤0.01%	1932
2017 Q2	$21K	Hold	10,045	–	–	﹤0.01%	1898
2017 Q1	$21K	Hold	10,045	–	–	﹤0.01%	1898
2016 Q4	$43K	Buy	10,045 +2,000	+25%	+$9.49K	﹤0.01%	1654
2016 Q3	$38K	Buy	8,045 +7,900	+5,448%	+$36K	﹤0.01%	1714
2016 Q2	$0	Hold	145	–	–	﹤0.01%	2911
2016 Q1	$0	Buy	+145	New	+$747	﹤0.01%	2869

Glenmede Trust's ARLZ Position: Q4 2019 in Review

Glenmede Trust sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2019, closing a stake of 16,000 shares.

Glenmede Trust first reported a position in ARLZ in Q1 2016 and held it in 15 quarters. The position peaked at $43K in Q4 2016. 0 funds tracked by Wall St. Rank hold ARLZ as of Q4 2019.

Glenmede Trust reported no remaining Aralez Pharmaceuticals Inc. position as of Q4 2019 after selling out during the quarter.
Glenmede Trust sold 16,000 Aralez Pharmaceuticals Inc. shares in Q4 2019.
Glenmede Trust first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 15 quarters.
Glenmede Trust's Aralez Pharmaceuticals Inc. position peaked at $43K in Q4 2016.
0 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.